Hip FracturesNCT06267937
Hip Fractures in Chile: Implications for Public Health Policy and Healthcare Delivery
An observational study of Hip Fractures, run by University of Chile at 1 site in Chile.
Trial summary
Hip fractures in individuals aged 60 and above pose significant challenges in terms of morbidity, mortality, and healthcare costs. While countries like the United Kingdom and Australia have optimized their healthcare systems for timely management of hip fractures, the situation in Chile presents distinct challenges… Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Hip Fractures
- What is being tested?
- Access to surgery and type of intitution
- Type of treatment
- Surgery or procedure
- How many people
- 46,380 participants
- Where
- 1 siteChile
- Study dates
- 10 Mar 2023to 30 Jan 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The chilean national database of hospital discharge and the chilean death registry from 2012 to 2018 were used. , The date of death was recorded for the 35,520 patients who had deceased; otherwise, they are classified as alive as of the current date. We remark that the national discharge and death databases use the same patient IDs, and therefore, we can easily identify those patients who have died during the period under analysis. We notice that we have used the hospital discharge database up to 2017 to have at least one year of follow-up for patients after a hip fracture.
Who may be able to join
- All patients in the national database between 2012 and 2017 which his principal was hip fracture. Diagnoses are classified using the International Classification of Diseases, 10th Revision (ICD-10) codes. A search was conducted for codes S72.0 (head and neck fracture of the femur), S72.1 (pertrochanteric fracture), and S72.2 (subtrochanteric fracture of the femur).
Who cannot join
- missing IDs ID with inconsistent socio-demographic information. Patients with primary diagnosis of hip fracture that underwent surgery but the national code surgery was not one of the following: : 2104128, 2104129, 2104131, 2104132, 2104135, 2104228, 2104229 and 2104231
Trial locations and contacts
1 site in 1 country.
Chile1 site
hospital Clinico Universidad de Chile
Santiago, Santiago Metropolitan, 8380456
About this study
Hip fractures in individuals aged 60 and above pose significant challenges in terms of morbidity, mortality, and healthcare costs. While countries like the United Kingdom and Australia have optimized their healthcare systems for timely management of hip fractures, the situation in Chile presents distinct challenges due to its mixed healthcare system. This study aims to assess survival rates following hip fractures in Chile and identify associated risk factors using national databases from 2012 to 2018. A comprehensive analysis of 35,520 patients revealed that factors such as age, type of health insurance, access to surgery, and treatment in public hospitals significantly influence mortality rates after hip fractures. The study found that patients with hip fractures experience lower 5-year survival rates compared to the general population, particularly when affiliated with public insurance and treated in public institutions. Modifiable factors like delayed surgery and prolonged hospital stays contribute to increased mortality rates. The findings underscore the urgent need for optimized public health policies and healthcare delivery systems to enhance outcomes for hip fracture patients in Chile.Hip fractures in individuals aged 60 and above pose significant challenges in terms of morbidity, mortality, and healthcare costs. While countries like the United Kingdom and Australia have optimized their healthcare systems for timely management of hip fractures, the situation in Chile presents distinct challenges due to its mixed healthcare system. This study aims to assess survival rates following hip fractures in Chile and identify associated risk factors using national databases from 2012 to 2018.
- Conditions
- Hip Fractures
- Being tested
- Access to surgery, type of intitution
- Medical subject headings
- Hip Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Access to surgeryProcedure or surgery
access to surgery after hip fracture
type of intitutionOther
public or private health care facility
| Study group | Role | What they receive |
|---|---|---|
| hip fracture | patients that were diagnosed with a hip fracture between 2012 and 2017 Receives: Procedure: Access to surgery; Other: type of intitution |
What is being measured
The primary outcome is the main question the study is designed to answer.
survival after hip fracture
survival after hip fracture
Measured: one to five years after the hip fracture
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2024
- Study start10 Mar 2023
- Primary completion10 Mar 2023
- Study completion30 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip FracturesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 46,380 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Chile
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, maximiliano barahona vasquez, University of Chile
- Investigators
- Susana Mondschein, PhD, Study chair, University of Chile
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06267937
- Sponsor's protocol ID
- 101
- Status last verified
- Feb 2024
- First submitted
- 12 Feb 2024
- Last updated
- 20 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Both National regestries are free access, nevertheless, the raw data will be made available after publication.
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hip Fractures in Chile: Implications for Public Health Policy and Healthcare Delivery
- ClinicalTrials.gov ID
- NCT06267937
- Acronym / sponsor ID
- 101
- Conditions
- Hip Fractures
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 46,380 participants (actual)
- Lead sponsor
- University of ChileUniversity, hospital or other
- Study start
- 10 Mar 2023 (actual)
- Primary completion
- 10 Mar 2023 (actual)
- Study completion
- 30 Jan 2024 (actual)
- First posted
- 20 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hip fractures in individuals aged 60 and above pose significant challenges in terms of morbidity, mortality, and healthcare costs. While countries like the United Kingdom and Australia have optimized their healthcare systems for timely management of hip fractures, the situation in Chile presents distinct challenges due to its mixed healthcare system. This study aims to assess survival rates following hip fractures in Chile and identify associated risk factors using national databases from 2012 to 2018. A comprehensive analysis of 35,520 patients revealed that factors such as age, type of health insurance, access to surgery, and treatment in public hospitals significantly influence mortality rates after hip fractures. The study found that patients with hip fractures experience lower 5-year survival rates compared to the general population, particularly when affiliated with public insurance and treated in public institutions. Modifiable factors like delayed surgery and prolonged hospital stays contribute to increased mortality rates. The findings underscore the urgent need for optimized public health policies and healthcare delivery systems to enhance outcomes for hip fracture patients in Chile.Hip fractures in individuals aged 60 and above pose significant challenges in terms of morbidity, mortality, and healthcare costs. While countries like the United Kingdom and Australia have optimized their healthcare systems for timely management of hip fractures, the situation in Chile presents distinct challenges due to its mixed healthcare system. This study aims to assess survival rates following hip fractures in Chile and identify associated risk factors using national databases from 2012 to 2018.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| hip fracture | – | Procedure: Access to surgery, Other: type of intitutionpatients that were diagnosed with a hip fracture between 2012 and 2017 |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The chilean national database of hospital discharge and the chilean death registry from 2012 to 2018 were used. , The date of death was recorded for the 35,520 patients who had deceased; otherwise, they are classified as alive as of the current date. We remark that the national discharge and death databases use the same patient IDs, and therefore, we can easily identify those patients who have died during the period under analysis. We notice that we have used the hospital discharge database up to 2017 to have at least one year of follow-up for patients after a hip fracture.
Key inclusion criteria (1 listed)
- All patients in the national database between 2012 and 2017 which his principal was hip fracture. Diagnoses are classified using the International Classification of Diseases, 10th Revision (ICD-10) codes. A search was conducted for codes S72.0 (head and neck fracture of the femur), S72.1 (pertrochanteric fracture), and S72.2 (subtrochanteric fracture of the femur).
Key exclusion criteria (1 listed)
- missing IDs ID with inconsistent socio-demographic information. Patients with primary diagnosis of hip fracture that underwent surgery but the national code surgery was not one of the following: : 2104128, 2104129, 2104131, 2104132, 2104135, 2104228, 2104229 and 2104231
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Access to surgeryaccess to surgery after hip fracture | Procedure or surgery | hip fracture |
| type of intitutionpublic or private health care facility | Other | hip fracture |
Primary outcome
survival after hip fracture
Time frame: one to five years after the hip fracture
survival after hip fracture
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2024.
- Individual participant dataSharing planned: Yes. Both National regestries are free access, nevertheless, the raw data will be made available after publication.
Related trials for Hip Fractures
Not yet recruitingPhase 4
Effect of Ondansetron on the Incidence of Spinal Anaesthesia-Induced Hypotension in Elderly Patients Undergoing Fracture Hip Surgery
Spinal Anaesthesia Induced Hypotension
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Active, not recruiting
Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery
Femoral Neck Fractures, Nerve Block
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Not yet recruiting
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
Hip Fracture Surgeries, High Risk Population of Hip Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Susana Mondschein, PhD study chair
University of Chile
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fractures, run by University of Chile at 1 site in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
survival after hip fracture (time frame: one to five years after the hip fracture). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.